[Effects of biotechnological cytochrome c on early postocclusion and reperfusion arrhythmias].
Balykova
L A
LA
Balashov
V P
VP
Kostin
Ia V
IaV
Sernov
L N
LN
D000208:Acute Disease; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000209:etiology; D001157:Arterial Occlusive Diseases / Q000150:complications*; D001709:Biotechnology; D002415:Cats; D003574:Cytochrome c Group / Q000494:pharmacology*; D004347:Drug Interactions; D005260:Female; D008297:Male; D015428:Myocardial Reperfusion Injury / Q000150:complications*
D000889:Anti-Arrhythmia Agents; D003574:Cytochrome c Group